PETNET SolutionsDelivering a broad portfolio of PET radiopharmaceuticals to advance patient outcomes

PETNET Solutions Inc, A Siemens Healthineers Company, reliably delivers PET radiopharmaceuticals via the largest network of cyclotron-equipped radiopharmacies globally. Supported by experts averaging more than 20 years of industry experience, PETNET customers unlock access to a wide array of tracers, customized data analytics, and educational resources to drive growth.

Case study

(Left to right) Shanon Kriz, regional director, Radiation Services, Sentara Health; Charlie Joyce, PETNET Solutions regional sales director; and Frances Vargas, regional PET/CT imaging manager, Sentara Health

As the patient demand for PET imaging grows, imaging centers need a reliable PET radiopharmaceutical partner to support them. Read the case study to learn how Sentara Health improves patient access and drives business growth with PETNET Solutions.

Our portfolio

Who we are

PETNET pharmacy illustrations

Customers in the United States have unique opportunities to participate in clinical trials with the support of PETNET. We are always collaborating with pharmaceutical companies to research new agents and submit drug applications. In addition to providing access to radiopharmaceuticals, we provide the training and support needed to participate in clinical trials across the United States.

 

PETNET cyclotron

Engineered 
reliability

Heavy investments in equipment design and redundancy increase uptime and output, upgrade cyclotron RF technology, and advance targetry, ion output, and control systems technologies.

PETNET pharmacy illustration

Proven on-time 
delivery

We use automated production, route optimization, and GPS technology to support on-time delivery in the US.

PETNET exemplifies high quality

Leading high quality production

Updates to our pharmacy information management system help ensure product quality and patient safety for customers within the US.

PETNET opens a new radiopharmacy site in Chicago.

Ongoing infrastructure investments

We are committed to continuing to invest heavily in our radiopharmacy sites to increase capacity, output, and operational efficiency. Last year, we opened 2 replacement radiopharmacy sites (and upgraded equipment, including cyclotrons, in several others).

Expert support

 

1
2